FIELD: biotechnology.
SUBSTANCE: method is developed to obtain in Saccharomyces cerevisiae yeast secreted fully functional phospholipase A2, including phospholipase A2 sequence of strain Streptomyces violaceoruber A-2688, including carrier mutation S31A, S82A and N108Q, and containing at N-end additional dipeptide, consisting of amino acid residues of serine and glycine. Proposed method involves biosynthesis of the precursor of the target protein, which is a version of phospholipase A2, containing an intein insertion between the glycine residue in position 75 and the serine residue in position 76. Invention also includes four precursor proteins which are encoded by sequences SEQ ID N: 1–4, respectively.
EFFECT: removing the intein insertion and converting the precursor protein into the active target protein by autocatalytic processing.
5 cl, 11 ex, 1 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| GENETIC CONSTRUCT CODING HUMAN YB-1 PROTEIN PRECURSOR, ESCHERICHIA COLI STRAIN - PRODUCER OF HUMAN YB-1 PROTEIN PRECURSOR, METHOD FOR MICROBIOLOGICAL SYNTHESIS OF SAID PRECURSOR | 2019 |
|
RU2728237C1 |
| METHOD OF CONTROL OF HEART RHYTHM AND REDUCTION OF INDIVIDUAL CARDIOMYOCYTES USING THERMOGENETICS | 2022 |
|
RU2802995C1 |
| MATERIALS AND METHODS USED FOR TREATMENT OF RESPIRATORY DISEASES IN DOGS | 2020 |
|
RU2811752C2 |
| COMPOSITIONS AND METHODS FOR BIOLOGICAL PRODUCTION OF LACTATE FROM C1-COMPOUNDS USING TRANSFORMANTS OF LACTATE DEHYDROGENASE | 2014 |
|
RU2710714C2 |
| HERPES VACCINE | 2019 |
|
RU2731073C1 |
| IMMUNO-INDUCING AGENT | 2016 |
|
RU2744843C2 |
| HIV-1 SUBTYPE A P17 PROTEIN ANTIBODIES | 2019 |
|
RU2727673C1 |
| INFLUENZA VIRUS CAPABLE OF INFECTING CANINES AND ITS USE | 2020 |
|
RU2802222C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT TUMOUR | 2016 |
|
RU2714205C2 |
| ORAL CARE PRODUCTS AND METHODS CONTAINING HLP | 2016 |
|
RU2759134C2 |
